started · updated
Bladder cancer: Experts warn hematuria is a critical symptom
Rossana Berardi, president-elect of the Italian Association of Medical Oncology (Aiom), has issued a warning regarding bladder cancer, emphasizing that hematuria—the presence of blood in urine—is a symptom that must not be underestimated. At the ESMO 2026 congress in Madrid, Berardi noted that delayed diagnosis often leads to the disease being identified only in locally advanced or advanced stages.
In Italy, approximately 29,000 new bladder cancer diagnoses are recorded annually, with roughly 23,000 of those cases occurring in men. Key risk factors include smoking, as well as certain professional and environmental exposures. Because there is no general population screening available, Berardi stressed the importance of prevention, early diagnosis, and a multidisciplinary medical approach involving urologists, oncologists, and radiotherapists.
Additionally, results from the phase 3 ‘Volga’ study were presented, demonstrating that a treatment combining perioperative durvalumab with neoadjuvant enfortumab vedotin reduced the risk of recurrence by 49% and the risk of death by 42% in patients with muscle-invasive bladder cancer.
Entities
Aiom · ESMO · Italy · Madrid · Rossana Berardi
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 4 SOURCES] The phase 3 ‘Volga’ study showed a 42% reduction in the risk of death for muscle-invasive bladder cancer patients using durvalumab and enfortumab vedotin. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it
- [● 4 SOURCES] Hematuria is the most frequent symptom of bladder cancer. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it
- [● 4 SOURCES] There is currently no screening program for bladder cancer directed at the general population. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it
- [● 4 SOURCES] About 23,000 of the annual bladder cancer diagnoses in Italy involve men. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it
- [● 4 SOURCES] The phase 3 ‘Volga’ study showed a 49% reduction in the risk of recurrence for muscle-invasive bladder cancer patients using durvalumab and enfortumab vedotin. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it
- [● 4 SOURCES] Approximately 29,000 new bladder cancer diagnoses are recorded annually in Italy. www.espressione24.it · cn24tv.it · www.lsdmagazine.com · quotidianodibari.it